Zuccotti Paola, Colombrita Claudia, Moncini Silvia, Barbieri Andrea, Lunghi Marta, Gelfi Cecilia, De Palma Sara, Nicolin Angelo, Ratti Antonia, Venturin Marco, Riva Paola
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano, Milan, Italy.
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Università degli Studi di Milano, Milan, Italy; IRCCS Istituto Auxologico Italiano, Cusano, Milan, Italy.
Biochim Biophys Acta. 2014 Jun;1839(6):506-16. doi: 10.1016/j.bbagrm.2014.04.018. Epub 2014 May 2.
Cyclin-dependent kinase 5 regulatory subunit 1 (CDK5R1) encodes p35, a specific activator of cyclin-dependent kinase 5 (CDK5). CDK5 and p35 have a fundamental role in neuronal migration and differentiation during CNS development. Both the CDK5R1 3'-UTR's remarkable size and its conservation during evolution strongly indicate an important role in post-transcriptional regulation. We previously validated different regulatory elements in the 3'-UTR of CDK5R1, which affect transcript stability, p35 levels and cellular migration through the binding with nELAV proteins and miR-103/7 miRNAs. Interestingly, a 138 bp-long region, named C2.1, was identified as the most mRNA destabilizing portion within CDK5R1 3'-UTR. This feature was maintained by a shorter region of 73 bp, characterized by two poly-U stretches. UV-CL experiments showed that this region interacts with protein factors. UV-CLIP assays and pull-down experiments followed by mass spectrometry analysis demonstrated that nELAV and hnRNPA2/B1 proteins bind to the same U-rich element. These RNA-binding proteins (RBPs) were shown to oppositely control CDK5R1 mRNA stability and p35 protein content at post-trascriptional level. While nELAV proteins have a positive regulatory effect, hnRNPA2/B1 has a negative action that is responsible for the mRNA destabilizing activity both of the C2.1 region and of the full-length 3'-UTR. In co-expression experiments of hnRNPA2/B1 and nELAV RBPs we observed an overall decrease of p35 content. We also demonstrated that hnRNPA2/B1 can downregulate nELAV protein content but not vice versa. This study, by providing new insights on the combined action of different regulatory factors, contributes to clarify the complex post-transcriptional control of CDK5R1 gene expression.
细胞周期蛋白依赖性激酶5调节亚基1(CDK5R1)编码p35,它是细胞周期蛋白依赖性激酶5(CDK5)的一种特异性激活剂。CDK5和p35在中枢神经系统发育过程中的神经元迁移和分化中起重要作用。CDK5R1的3'-非翻译区(3'-UTR)不仅长度显著,而且在进化过程中高度保守,这强烈表明它在转录后调控中发挥重要作用。我们之前验证了CDK5R1的3'-UTR中的不同调控元件,这些元件通过与nELAV蛋白和miR-103/7微小RNA(miRNA)结合,影响转录本稳定性、p35水平和细胞迁移。有趣的是,一个名为C2.1的138碱基对长的区域被确定为CDK5R1的3'-UTR中最能使mRNA不稳定的部分。这一特征在一个73碱基对的较短区域得以保留,该区域的特点是有两个多聚尿嘧啶序列。紫外交联免疫沉淀(UV-CL)实验表明,该区域与蛋白质因子相互作用。紫外交联免疫沉淀(UV-CLIP)分析以及随后的下拉实验和质谱分析表明,nELAV和异质性核糖核蛋白A2/B1(hnRNPA2/B1)蛋白与同一个富含尿嘧啶的元件结合。这些RNA结合蛋白(RBP)在转录后水平上对CDK5R1 mRNA稳定性和p35蛋白含量发挥相反的调控作用。虽然nELAV蛋白具有正向调控作用,但hnRNPA2/B1具有负向作用,它负责C2.1区域和全长3'-UTR的mRNA不稳定活性。在hnRNPA2/B1和nELAV RBP的共表达实验中,我们观察到p35含量总体下降。我们还证明,hnRNPA2/B1可以下调nELAV蛋白含量,但反之则不然。这项研究通过提供关于不同调控因子联合作用的新见解,有助于阐明CDK5R1基因表达复杂的转录后调控机制。